发明名称 9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
摘要 The present invention relates to a compound of formula (I),; which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing these compounds, particularly pharmaceutical formulations suitable for inhalation and their use for the treatment of diseases, particularly tumoral diseases, benign prostatic hyperplasia and diseases of the lungs and airways.
申请公布号 US8906931(B1) 申请公布日期 2014.12.09
申请号 US201414471147 申请日期 2014.08.28
申请人 Boehringer Ingelheim International GmbH 发明人 Pfrengle Waldemar;Huchler Guenther;Ostermeier Markus;Sieger Peter
分类号 C07D401/00;A01N43/54;A61K31/517 主分类号 C07D401/00
代理机构 代理人 Morris Michael P.;Lazer Edward S.
主权项 1. A method for the treatment of inflammatory or allergic diseases of the airways comprising administering a therapeutically effective amount of the compound of formula (I), characterized in that reflections in the X-ray powder diagram occur at dhkl values of 7.11, 5.77, 4.69, 4.36, 4.15, 3.85 and 3.61 Å, optionally in the form of a tautomer thereof, to a patient in need thereof
地址 Ingelheim am Rhein DE